Susquehanna International Group
ABMD

Susquehanna International Group’s Abiomed Inc ABMD Stock Holding History

Susquehanna International Group’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-61,600
Closed -$15.1M – 14357
2022
Q3 		$15.1M Buy
61,600
+34,600
+128% +$9.34M ﹤0.01% 1695
2022
Q2 		$6.68M Sell
27,000
-7,400
-22% -$2M ﹤0.01% 2750
2022
Q1 		$11.4M Sell
34,400
-76,200
-69% -$23.5M ﹤0.01% 2383
2021
Q4 		$39.7M Buy
110,600
+4,200
+4% +$1.42M 0.01% 1270
2021
Q3 		$34.6M Buy
106,400
+25,200
+31% +$8.54M ﹤0.01% 1452
2021
Q2 		$25.3M Sell
81,200
-10,700
-12% -$3.28M ﹤0.01% 1778
2021
Q1 		$29.3M Sell
91,900
-51,200
-36% -$16.4M ﹤0.01% 1498
2020
Q4 		$46.4M Buy
143,100
+17,200
+14% +$4.76M 0.01% 1060
2020
Q3 		$34.9M Sell
125,900
-7,400
-6% -$2.13M 0.01% 1082
2020
Q2 		$32.2M Sell
133,300
-29,200
-18% -$5.86M 0.01% 1072
2020
Q1 		$23.6M Buy
162,500
+37,500
+30% +$6.23M 0.01% 1075
2019
Q4 		$21.3M Buy
125,000
+1,300
+1% +$241K 0.01% 1356
2019
Q3 		$22M Buy
123,700
+10,600
+9% +$2.29M 0.01% 1267
2019
Q2 		$29.5M Buy
113,100
+26,600
+31% +$7.06M 0.01% 1022
2019
Q1 		$24.7M Sell
86,500
-12,700
-13% -$4.22M 0.01% 1039
2018
Q4 		$32.2M Sell
99,200
-85,600
-46% -$29.7M 0.01% 794
2018
Q3 		$83.1M Buy
184,800
+57,800
+46% +$22.8M 0.03% 500
2018
Q2 		$51.9M Buy
127,000
+44,600
+54% +$16.2M 0.02% 671
2018
Q1 		$24M Buy
82,400
+42,700
+108% +$10.8M 0.01% 1091
2017
Q4 		$7.44M Sell
39,700
-10,700
-21% -$2M ﹤0.01% 2100
2017
Q3 		$8.5M Buy
50,400
+23,800
+89% +$3.6M ﹤0.01% 1922
2017
Q2 		$3.81M Buy
26,600
+8,100
+44% +$1.09M ﹤0.01% 2768
2017
Q1 		$2.32M Buy
18,500
+9,800
+113% +$1.14M ﹤0.01% 3444
2016
Q4 		$980K Sell
8,700
-29,400
-77% -$3.41M ﹤0.01% 5576
2016
Q3 		$4.9M Sell
38,100
-32,000
-46% -$3.83M ﹤0.01% 2263
2016
Q2 		$7.66M Sell
70,100
-35,000
-33% -$3.48M ﹤0.01% 1699
2016
Q1 		$9.96M Buy
105,100
+61,200
+139% +$5.17M 0.01% 1568
2015
Q4 		$3.96M Sell
43,900
-55,300
-56% -$4.69M ﹤0.01% 2851
2015
Q3 		$9.2M Buy
99,200
+67,200
+210% +$5.92M ﹤0.01% 1921
2015
Q2 		$2.1M Buy
32,000
+300
+0.9% +$19.9K ﹤0.01% 4615
2015
Q1 		$2.27M Sell
31,700
-4,300
-12% -$233K ﹤0.01% 4081
2014
Q4 		$1.37M Buy
36,000
+25,500
+243% +$804K ﹤0.01% 5230
2014
Q3 		$261K Buy
10,500
+1,700
+19% +$43.1K ﹤0.01% 8240
2014
Q2 		$221K Sell
8,800
-15,000
-63% -$349K ﹤0.01% 8894
2014
Q1 		$620K Sell
23,800
-5,000
-17% -$138K ﹤0.01% 6373
2013
Q4 		$770K Buy
28,800
+10,100
+54% +$250K ﹤0.01% 5959
2013
Q3 		$357K Sell
18,700
-33,500
-64% -$766K ﹤0.01% 6952
2013
Q2 		$1.13M Buy
+52,200
New +$1.05M ﹤0.01% 4796

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $537M AUM 18.24% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Susquehanna International Group's ABMD Position: Q4 2022 in Review

Susquehanna International Group sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 971 shares — an estimated $239K sold.

Susquehanna International Group first reported a position in ABMD in Q3 2013 and held it in 34 quarters. The position peaked at $29.9M in Q2 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Susquehanna International Group reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Susquehanna International Group sold 971 Abiomed Inc shares in Q4 2022, an estimated $239K.
  • Susquehanna International Group first reported a position in Abiomed Inc in Q3 2013 and held it in 34 quarters.
  • Susquehanna International Group's Abiomed Inc position peaked at $29.9M in Q2 2018.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Susquehanna International Group's 13F filing for Q4 2022, filed 14 Feb 2023.